Budite u toku

To je novo u Wörwag Pharma

22.02.2024

Wörwag Pharma: success instead of bottle necks

Böblingen, February 22, 2024 – Wörwag Pharma closed the 2023 financial year with an organic sales growth of 7.6 percent – despite the tense situation…

Pročitajte informacije za štampu

22.01.2024

Mauermann becomes Wörwag Pharma Production

Böblingen, January 22, 2024 – With the renaming of the most recent investment Mauermann Arzneimittel GmbH & Co. KG, Wörwag Pharma is taking the next…

Pročitajte informacije za štampu

16.03.2023

Wörwag Pharma invests in further growth

Böblingen, March 16, 2023 – The Böblingen-based pharmaceutical and family-owned company Wörwag Pharma closed the 2022 financial year with an increase…

Pročitajte informacije za štampu

17.02.2022

[Translate to Montenegrin:] Wörwag Pharma invests in own production

Böblingen, February 17, 2022 – The Boeblingen-based family-owned company Wörwag Pharma invested in several strategic milestones in 2021 and…

Pročitajte informacije za štampu

13.11.2021

[Translate to Montenegrin:] Fritz-Wörwag-Research-Prize: New scientific findings from biofactor research honored

In order to support science and research, Wörwag Pharma has awarded the 10th Fritz Wörwag Research Prize this year. The prize rewards new research…

Pročitajte informacije za štampu

04.05.2021

[Translate to Montenegrin:] Wörwag Pharma acquires produciton com pany in Poland

Böblingen/Lódz – German pharmaceutical company Wörwag Pharma GmbH & Co. KG announces the acquisition of Sensilab, contract manufacturer and…

Pročitajte informacije za štampu

Vaša kontakt osoba

Monika Wörwag

Director Communications

press@woerwagpharma.com

Informacije za predstavnike medija

Novinari i urednici mogu koristiti ovde dostupne slike besplatno i samo u uredničke svrhe, pod uslovom da kao izvor navedu "Wörwag Pharma". Grafičke promene nisu dozvoljene. Pošaljite svoje besplatne primerke na press@woerwagpharma.com.